Navigation Links
Non-white med students reject therapies associated with their culture
Date:11/17/2008

WASHINGTON, DC -- Non-white medical students are more likely to embrace orthodox medicine and reject therapies traditionally associated with their cultures. That is one finding from an international study that measures the attitudes of medical students toward complementary and alternative medicine (CAM). While seemingly counter-intuitive, white students view CAM more favorably than their non-white counterparts, the study authors say.

CAM is the common, collective term that describes non-orthodox therapies considered not intrinsic to the politically dominant health system of a particular society or culture.

Despite the growing popularity of CAM, many medical schools do not include CAM teachings within basic medical education. So researchers at four medical schools (Peninsula, UK; Birmingham, UK; Georgetown, USA; and Auckland, NZ) conducted two surveys to measure the attitudes of medical students toward CAM during their first and fourth year of medical training in schools that offer some CAM education either at the undergraduate or graduate level. The study is published online in Medical Teacher.

"The first study we conducted with first-year medical students indicated that overall, students wanted more information about CAM in their curriculum," said Hakima Amri, PhD, director of the Complementary and Alternative Medicine Program at Georgetown University Medical Center, the only science-based CAM Master's program at an academic institution in the United States. Amri is a co-investigator and the lead author of the US component of the study. "Our follow-up study measured attitude changes about CAM during medical training. We didn't observe a significant change in overall attitude between the first and fourth year, but we did spot some other interesting trends."

Amri says in the first study, U.S. medical students wanted more courses about CAM than students in Hong Kong, for example. (The Hong Kong school was not in
'/>"/>

Contact: Karen Mallet
km463@georgetown.edu
414-312-7085
Georgetown University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Non-whites receive harsher sentences for inflicted traumatic brain injury of children
2. Non-White Women More Prone to Breast Cancer Pain
3. MyMedicalAssistingDegree.com Provides School-Search Help for Students
4. Rutgers College of Nursing professor and her 2 students receive PSN Editors Award
5. Highmark Healthy High 5 School Challenge Grant Program Enables Pennsylvania Schools to Implement or Enhance Healthy Lifestyle Programs for Students
6. University of Minnesota Study Says Students Eat More Whole Grains When Gradually Added to School Foods
7. Stater Bros. Charities, KFRG Radio Stations and Loma Linda University Childrens Hospital Will Present More Than 1,100 Brand-New Bikes to 4th Grade Students!
8. Big Money in Bad Times: AFSA Offers Scholarships for Struggling Students
9. mtvU and The Jed Foundation Ask Students How Are You A Friend?
10. The Largest and Most Comprehensive College Dating and Sex Survey Uncovers Surprising Behaviors of Students In and Out of the Bedroom
11. College Students Seek Healthcare Solutions on Eve of Debate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)... SAN FRANCISCO, Jan. 8 M... that David Hung, M.D., president and chief,execu... Morgan Healthcare,Conference on Wednesday, Janua...t. Francis Hotel in San Francisco. , Dr. Hu...clinical,development programs for Dimebon for Alz...
(Date:1/8/2009)...HINGTON, Jan. 8 The Pew...son has been named director, chemical and food saf...olicy program. Olson, who was formerly deputy staf...ttee on Environment and Public Works, brings nearl...nd consumer advocacy to Pew. , , "We are excit...
(Date:1/8/2009)...ould be used when assessing traditional risk facto...althDay News) -- Two molecular signs -- or "biomar...ation when trying to assess a person,s risk of str... or very low risk, adding these markers does not c...ay Nambi, a cardiologist at the Methodist DeBakey ...
(Date:1/8/2009)...hy Tune Promoted to Principal. Christine Siu and ..., MINNEAPOLIS, SAN FRANCISCO and STAMFORD, Conn.,...tners, a health care venture capital firm that inv...ies, today announced the promotion of three member...moted to Principal. Christine Siu and Jason Brown...
Breaking Medicine News(10 mins):Health News:Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference 2Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Inflammation Markers May Help Predict Stroke Risk 2Health News:Inflammation Markers May Help Predict Stroke Risk 3Health News:Thomas, McNerney & Partners Promotes Three Members of Its Investment Team 2
... to findings of a recent study , 70 percent of all... ill individuals.// Researchers studied nearly 43,...p homes to explore the correlation between patient...nd drug use. Results showed 28 percent of patients...
...rs now say they’ve found one drug that may success...cer.// In a study of 22 patients with breast, pros...42 percent had their tumors either stabilize or sh...y , it turns off one of the switches within the ca...
...of a new study shows that high-doses of vitamin E...erall risk of early death.// Vitamin E is one of ...wth and function. On average, dietary intake of vi...y. Other sources of the vitamin include wheat germ...
...rs say there may be a new way to correct hard-to-t...g during a minimally // invasive surgical procedur...ure a more complete correction. Birthmarks basica...le with the birthmarks do not experience problems,...
Other Medicine News:
(Date:1/6/2009)...swire-FirstCall/ -- , - Early Renewal of th...ember 2011 , - Expansion of the Scope of th...Ophthalmology , - Revised Commercial Terms ...o a Third Party , ExonHit Therapeutics (A...of its existing drug discovery collaboration with ...
(Date:12/30/2008)...ewswire/ -- The Coalition for 21st Century Medicin...enentech, Inc. on December 5, 2008, seeking to res...tic tests to physicians and patients. The request...arm patient care and rests on flawed scientific an...s to encourage the research, development, and comm...
(Date:12/17/2008)...t and validation of non-animal alternative test me...re/ -- MatTek Corporation today announced that the...ed the scientific validity of the Modified EpiDerm...g. ESAC concluded that the Modified EpiDerm SIT h...diction of skin irritating and non-irritating test...
(Date:12/17/2008)...l/ -- Delcath Systems, Inc. (Nasdaq: DCTH ) toda...h.D., to Delcath,s Board of Directors. Dr. Contag...perience working with international and domestic i....com/cgi-bin/prnh/20081118/NY46990LOGO ) , ,... 2006 and served as CEO. Prior to starting Cobalt...
Breaking Medicine Technology:ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 2Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 4EpiDerm's Skin Irritation Test Fully Validated in European Union 2Delcath Adds Dr. Pamela R. Contag to Its Board of Directors 2Delcath Adds Dr. Pamela R. Contag to Its Board of Directors 3Dragon retains leading investor relations firm 3999 1Dragon retains leading investor relations firm 3999 2Dragon retains leading investor relations firm 3999 3QuoNova Global Executive Appointments 3994 1QuoNova Global Executive Appointments 3994 2QuoNova Global Executive Appointments 3994 3QuoNova Global Executive Appointments 3994 4Fludarabine Mitoxantrone and Zevalin 28R 29 Produces 96 25 Complete Remission Rate in First Line Treatment of Patients with Follicular Non Hodgkins L 1531 1Fludarabine Mitoxantrone and Zevalin 28R 29 Produces 96 25 Complete Remission Rate in First Line Treatment of Patients with Follicular Non Hodgkins L 1531 2Fludarabine Mitoxantrone and Zevalin 28R 29 Produces 96 25 Complete Remission Rate in First Line Treatment of Patients with Follicular Non Hodgkins L 1531 3Fludarabine Mitoxantrone and Zevalin 28R 29 Produces 96 25 Complete Remission Rate in First Line Treatment of Patients with Follicular Non Hodgkins L 1531 4New Brain Fitness Training Promotes Health and Independence of Long Term Care Insurance Policyholders 14470 1New Brain Fitness Training Promotes Health and Independence of Long Term Care Insurance Policyholders 14470 2New Brain Fitness Training Promotes Health and Independence of Long Term Care Insurance Policyholders 14470 3
...ries, Inc. Today,Announced the Top Line Results of...) Study with the Compound Desmoteplase , Aachen (G...k,Exchange, Prime Standard: PA8) and its US partne...unced topline results of,the DIAS-2 (Desmoteplase ...Desmoteplase. The Phase III study was designed to,...
...tCall/ - Research,collaborators with Oncolytics Bi... a poster presentation covering REOLYSIN(R),clinic...Oncology,(ASCO) Annual Meeting, to be held June 1-...f Oncolytics, U.K. Phase I systemic,administration... Phase I Study of,Wild-Type Oncolytic Reovirus Adm...
Other Medicine Technology:Top Line Results of Phase III Study in Acute Ischemic Stroke,(DIAS-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 2Top Line Results of Phase III Study in Acute Ischemic Stroke,(DIAS-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 3Top Line Results of Phase III Study in Acute Ischemic Stroke,(DIAS-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 4Oncolytics Biotech Inc.'s Research Collaborators to Present,REOLYSIN Clinical Trial Data at ASCO Conference 2
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products: